Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT03037814
Starting soon Not applicable

Clinical Performance of Restorative Materials in Primary Teeth

NCT03037814 · tracked via the Priya Life Science Turkey tracker
Sponsor
Hacettepe University
Phase
Not applicable
Started
2021-09-28
Last updated
2021-03-15

Condition(s) studied

Caries; DentinDental Caries

Investigational drug(s) / intervention(s)

CompomerRMGICGiomerAmalgam

Compomer: Aesthetic resin dental materials that are used to replace structure loss, commonly for dental caries of primary tooth. Compomers designed to combine the aesthetics of traditional composite resins with the fluoride release and adhesion of glass-ionomer cements.

RMGIC: Dental restorative materials that are a combination of the desirable properties of glass-ionomer (fluoride release and chemical adhesion) with high strength and low solubility of resins.

Giomer: Giomers are dental materials that are hybrid of compomers and glass ionomers, and are used to restore dental caries.

Amalgam: Amalgam is a silver-colored dental restorative material that can be used to restore both primary and permanent posterior teeth which have dental caries.

Study summary

The purpose of this study is to evaluate and compare the clinical performance of dental restorative materials in Class II cavities of primary molar teeth

Eligibility

Sex
ALL
Min age
4 Years
Max age
7 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients and parent of the patients who accept to participate and sign the informed consent * Patients who have at least four first and/or second primary molars with proximal caries that require class II restorations * Teeth that have healthy lamina dura and periodontal ligament * Teeth that have caries lesions extending no more than the outher half of dentin radiographically Exclusion Criteria: * Patients and parent of the patients who don't accept to participate and sign the informed consent * Teeth that are previously restored * Patients who are uncooperative * Teeth that doesn't have proximal or occlusal contacts with adjacent healthy teeth * Patients who have bruxism, skeletal or dental malocclusion * Teeth that have developmental defects or anomalies

Primary outcome measure(s)

  • Clinical evaluation of restorative materials in class II cavities on primary molar teeth according to the modified USPHS criteria — 5 years
    Long-term clinical success of different restorative materials in class II cavities on primary molar teeth

Trial sites (1)

FacilityCityRegionStatus
Hacettepe University Ankara Turkey (Türkiye)

More Hacettepe University trials in Turkey

Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients Recruiting
Effects of Rigid Taping in Acromioclavicular Joint Degeneration Recruiting
Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Kidney Transplantation Recruiting
Clinical Evaluation of a Restorative Glass Ionomer and a Bulk-fill Composite Resin Active, not recruiting
Physical Functions and Lifestyle Behaviours in Post-COVID-19 Syndrome Based on Circadian Rhythms Recruiting

Other trials for the same condition

Clinical Comparison of Restorative Materials Active, not recruiting
Clinical Evaluation of the Retention of Fissure Sealants Applied Following Guided Biofilm Therapy and Conventional Polishing Starting soon
Hall Technique vs Conventional Technique in Permanent Teeth Starting soon
DETERMINATION OF THE EFFECTS OF STAINLESS STEEL CROWNS CEMENTED WITH RESIN CEMENTS ON INTERLEUKIN-10, 12, 18 LEVELS IN GINGIVAL CREVICULAR FLUID Starting soon
Comparison of Clinical Performance of Partial Restorations Fabricated With Three-Dimensional Printer and CAD-CAM Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03037814 on ClinicalTrials.gov ↗ ← All trials in Turkey